SANOFI-AVENTIS (EPA:SAN) Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis
Directive transparence : information réglementée
26/02/2022 18:05
01/06/2023 07:30
01/06/2023 07:30
21/05/2023 20:17
21/05/2023 20:17
17/05/2023 22:01
17/05/2023 22:01
12/05/2023 10:50
04/05/2023 08:00
04/05/2023 08:00
27/04/2023 14:40